Shijiazhuang No.4 Pharmaceutical Group: Low-calcium peritoneal dialysis solution and other drugs obtain drug production registration approval

date
19/11/2026
SSY Group announced that the group has obtained drug production registration approvals from China's National Medical Products Administration for low-calcium peritoneal dialysis solution, peritoneal dialysis solution, peritoneal dialysis solution, and low-calcium peritoneal dialysis solution, all in 2000ml specifications, belonging to Category 3 chemical drugs and deemed to have passed consistency evaluation, among which the low-calcium peritoneal dialysis solution is the third approved by a domestic enterprise. These products are mainly used for peritoneal dialysis in patients with chronic renal failure, and are used when hypermagnesemia has not been sufficiently improved.